Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
JOHNSON & JOHNSON | EVP, Chief EI and Med Officer | Common Stock | 38.6K | $6.1M | $157.85 | Feb 13, 2024 | Direct |
JOHNSON & JOHNSON | EVP, Chief EI and Med Officer | Employee Stock Options (Right to Buy) | 34.7K | $3.14M | $90.44 | Feb 15, 2024 | Direct |
JOHNSON & JOHNSON | EVP, Chief EI and Med Officer | Restricted Share Units | 2.16K | $340K | $157.85 | Feb 15, 2024 | Direct |
JOHNSON & JOHNSON | EVP, Chief EI and Med Officer | Performance Share Units | 0 | $0 | $157.40 | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JNJ | JOHNSON & JOHNSON | Feb 15, 2024 | 2 | $0 | 4 | Feb 20, 2024 | EVP, Chief EI and Med Officer |
JNJ | JOHNSON & JOHNSON | Feb 13, 2024 | 3 | -$67.4K | 4 | Feb 15, 2024 | Officer |
JNJ | JOHNSON & JOHNSON | Feb 12, 2024 | 4 | -$642K | 4 | Feb 14, 2024 | Officer |
JNJ | JOHNSON & JOHNSON | Feb 8, 2024 | 3 | -$174K | 4 | Feb 12, 2024 | Officer |
JNJ | JOHNSON & JOHNSON | Aug 23, 2023 | 1 | $0 | 4 | Aug 25, 2023 | Officer |
JNJ | JOHNSON & JOHNSON | Jul 26, 2023 | 3 | -$1.2M | 4 | Jul 27, 2023 | Officer |
JNJ | JOHNSON & JOHNSON | Feb 13, 2023 | 4 | -$743K | 4 | Feb 15, 2023 | Officer |
JNJ | JOHNSON & JOHNSON | Feb 10, 2023 | 3 | -$227K | 4 | Feb 14, 2023 | Officer |
JNJ | JOHNSON & JOHNSON | Oct 24, 2022 | 4 | -$1.22M | 4 | Oct 26, 2022 | Title: Chief External Innovation and Medical Safety Officer |
JNJ | JOHNSON & JOHNSON | Apr 21, 2022 | 10 | -$2.77M | 4 | Apr 25, 2022 | Officer |
JNJ | JOHNSON & JOHNSON | Feb 14, 2022 | 5 | $4.9M | 4 | Feb 18, 2022 | Officer |
JNJ | JOHNSON & JOHNSON | Feb 14, 2022 | 3 | -$529K | 4 | Feb 15, 2022 | Officer |
JNJ | JOHNSON & JOHNSON | Jan 3, 2022 | 0 | $0 | 3/A | Feb 12, 2024 | Title: EVP, Chief External Innovation and Medical Officer |
JNJ | JOHNSON & JOHNSON | Jan 3, 2022 | 0 | $0 | 3/A | Feb 18, 2022 | Officer |